# Lithium for Parkinson's: an Extension Trial

> **NCT06592014** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **State University of New York at Buffalo** · enrollment: 35 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Lithium aspartate

## Key facts

- **NCT ID:** NCT06592014
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-09
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592014, "Lithium for Parkinson's: an Extension Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06592014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
